Skip to main content
← All topics Watch the film · 1:46 Measured in the Enginerds corpus

Orna Therapeutics

Orna Therapeutics appears in 5 analyzed articles across the measured technology press. Recent coverage is steady, counting every mention over recent months. This page shows the public snapshot: movement, coverage mix, recent sources, and what drove the latest change.

Compass measures press coverage, not Orna Therapeutics's product quality, business performance, or market value.

What's happening with Orna Therapeutics?

Counting every mention, coverage of Orna Therapeutics is steady — it appears in 5 analyzed articles across the technology press.

Coverage Mix
Orna Therapeuticscompany
5 classified coverage items · 5 measured articles · Feb 2026 – Apr 2026

What Orna Therapeutics coverage is made of over time: story type, claim stage as reported, and press framing. This measures the coverage, not the product.

Across 5 classified coverage items, one item is 20 percentage points — read the shares below as the shape of a small sample, not as figures precise to the point.

Story type and claim stage are shares of the 5 classified coverage items in this window.

VolumeToo short a window for a trend read ·
Make-upMostly Acquisition · 100% by story type
Framing Mostly neutral
How to read this

The stream below stacks each month's coverage by the lens you choose: Tone (how the press frames the story — promotional, skeptical, critical, or neutral), Story type (launches, funding, lawsuits, partnerships…), or Stage — how far the reported claim has gone: speculation → announcement → launch → results.

Taller bands mean more coverage that month; the dots beneath mark notable non‑neutral events. Every signal is sourced and dated.

Coverage is 60% announcement-stage (by claim stage) and overwhelmingly neutral in tone; its biggest storyline is Acquisition · Eli Lilly.
Corporate coverage — the stage ladder reflects how far this company's announced moves had progressed, not a verdict on the company.
Coverage items
5
Lead specific story type
Acquisition 100%
Notable framing
Mostly neutral
Trend lens
y‑axis: items with readable framing / month
Neutral
nowpeak · 201235Feb '26Mar '26Apr '26
Click any month to see what drove it
Want the full workspace? A free account opens the full instrument — Coverage, Connections, and Compare, on Orna Therapeutics or any other topic. Free reads each tab over the last 30 days, and a full sourced report on any topic is $19, one-time; Pro and Plus are the same instrument at full capacity — 15 months of history, reports included, watches, and alerts. The full-record chart on this page stays free to browse either way.
What Compass measures here
Recent direction→ mixed / steady
Articles5
Persistence (current)0 mo
Persistence (longest)3 mo
Company and project posts

1 post on company and project channels mentions Orna Therapeutics across the full 15-month record. They come from any company or project channel Compass reads, not only Orna Therapeutics's own. They are counted separately from the 5 press articles.

Jul 2025Posts per monthOct 2026

Where they were published:MIT News - Artificial intelligence · 1

Press coverage and company and project posts are two separate counts. Every press figure on this page, including the monthly line and the rising or falling call, comes from the independent press only. Before October 2026, Compass counted these posts as press coverage. How this is measured.

As of 7 Oct 2026 · corpus coverage 94% · 356,656 articles. Correlational & coverage-limited.

Keep watching Orna Therapeutics with Pro
  1. ✓
    This snapshotDirection, footprint & coverage make-up — free, no account, always
  2. 🔒
    Full history & coverage trailMonth-by-month make-up & every cited source
  3. 🔒
    ConnectionsThe topics it's most often covered alongside
  4. 🔒
    Compare & exportBenchmark vs. other topics; export the source pack
  5. 🔒
    Watchlist & alertsGet pinged when the make-up or direction shifts
Keep watching Orna Therapeutics with Pro — from $59/mo → What is Compass? →
Source: Enginerds Compass — measurements over a longitudinal technology corpus. Not investment advice. © Enginerds. Counted over the published source panel.